Analysed COGENT BIOSCIENCES INC (COGT:NASDAQ) News Sources
Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
21-04-2026
yahoo.com
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
17-04-2026
yahoo.com
Does Bezuclastinib’s Real-Time FDA Review and NDA Filing Change The Bull Case For Cogent Biosciences (COGT)?
12-04-2026
yahoo.com
Southwest Airlines, Colliers International, and More Stocks See Action From Activist Investors
10-04-2026
yahoo.com
Cogent Biosciences (COGT): Billionaire Stan Druckenmiller Admires Upside Potential of This Stock
08-04-2026
yahoo.com
Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)
01-04-2026
yahoo.com
Cogent Biosciences, Cigna Group among top healthcare stocks, according to UBS analysts
30-03-2026
proactiveinvestors.com
A Look At Cogent Biosciences (COGT) Valuation After FDA NDA Acceptance And Shifting Institutional Positions
23-03-2026
yahoo.com
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
21-03-2026
fool.com
What is the current price of COGENT BIOSCIENCES INC (COGT:NASDAQ)?
The current price of COGENT BIOSCIENCES INC (COGT:NASDAQ) is $36.73.
COGENT BIOSCIENCES INC (COGT:NASDAQ) absolute price change since previous trading day?
The absolute price change of COGENT BIOSCIENCES INC (COGT:NASDAQ) since the previous trading day is $-0.27.
COGENT BIOSCIENCES INC (COGT:NASDAQ) percentage price change since previous trading day?
The percentage price change of COGENT BIOSCIENCES INC (COGT:NASDAQ) since the previous trading day is -0.7297%.
What is the most recent average sentiment score for COGENT BIOSCIENCES INC (COGT:NASDAQ)?
The most recent average sentiment score for COGENT BIOSCIENCES INC (COGT:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for COGENT BIOSCIENCES INC (COGT:NASDAQ)?
The most recent sentiment for COGENT BIOSCIENCES INC (COGT:NASDAQ) is .
SEC-8K** Filing Available For COGENT BIOSCIENCES INC (COGT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.